zibp Zentrum fuer Infektiologie Berlin Prenzlauer Berg GmbH — Clinical Trial Site

10 Registered trials

1 Currently recruiting

Organisation

zibp Zentrum fuer Infektiologie Berlin Prenzlauer Berg GmbH

Location

Berlin, Germany

Identifier

ORG-100044172

Address

Driesener Straße 23, Prenzlauer Berg, 10439, Germany

Departments

Infektiologie
n/a
NA
Prenzlauer Berg GmbH
zibp Zentrum für Infektiologie
zibp Zentrum für Infektiologie Berlin

Clinical trials at this site (10)

Search interface

A clinical study of people with HIV‐1 who switch their treatment to a combination of doravirine and islatravir Not authorised

2022-502079-49-00 HIV-1 infection 5
A clinical study of people with HIV-1 who received prior treatment combination of doravirine and islatravir Not authorised

2022-502126-40-00 HIV-1 infection 5
Study of Oral Weekly GS-1720 and GS-4182 Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed Pending

2024-511054-50-00 HIV-1 Infection 10
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients with Coronavirus Disease 2019 (COVID-19) who ar… Recruiting

2024-517727-39-00 Covid-19 at high risk of progression to severe illness. 5 2025-07-28
PH 3b, CAB + RPV in people with suboptimal response to oral ART (CROWN) Ended

2024-515070-28-00 HIV Infections 5 2024-12-23
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen Ended

2022-500929-33-01 Human Immunodeficiency Virus (HIV-1) infection 10 2023-05-17
Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Expos… Ended

2022-501763-40-00 Pre-Exposure Prophylaxis of HIV-1 Infection 5 2016-12-13
HIV: Budigalimab and/or ABBV-382 in People Living with HIV on Stable Antiretroviral Therapy Ended

2023-505900-53-00 HIV infection 4 2024-04-08
A study on the reactogenicity, safety, immune response, and efficacy of a targeted immunotherapy against HSV in healthy participants aged 18… Ended

2024-510571-37-00 Herpes Simplex 7 2023-12-06
Phase 3 Study of Bepirovirsen in Nucleos(t)ide Analogue-treated Participants with Chronic Hepatitis B (B-Well 1) Ended

2023-504239-41-00 Hepatitis B, Chronic 5 2023-01-09